(PubMed) Haristoy X, Angioi-Duprez K, Duprez A, Lozniewski A
If you have type 2 diabetes or another metabolic condition, medication changes may need closer monitoring because blood glucose targets before and during pregnancy are different from routine weight-loss goals
This ensures medication timing, dose escalation, and monitoring align with your broader cancer care plan and any other concurrent treatments
Over time, aim to consistently hit your protein goals and include a variety of foods
GIP receptors are found throughout the body, and their activation improves how cells respond to insulin (insulin sensitivity) and appears to promote more favorable fat distribution (less visceral fat around organs, more subcutaneous fat under the skin)
Persistent diarrhea beyond six weeks at stable dose suggests either an underlying GI condition unrelated to tirzepatide or a need to reduce dose permanently